Aegerion Pharmaceuticals (AEGR) - NASDAQ
  • SA Transcripts | Send Message 16 Jun

    Aegerion Pharmaceuticals And QLT Inc. Strategic Merger Call Slides $AEGR http://seekingalpha.com/a/2dcsx
    Reply
      • Colin Macleod | Send Message 15 Jun

        Clay Trader Aegerion Pharma Inc - $AEGR Stock Chart Technical Analysis for 06-15-16 http://tinyurl.com/hu77g3j
        Reply
          • timtrading | Send Message 15 Jun
            Reply
              • timothy russell | Send Message 15 Jun

                Some Great moves in market this morning on $AEGR $CLRB $BSPM $LBIX $EXAS $MGT.. ALL within 30 minutes!
                Reply
                  • timothy russell | Send Message 15 Jun

                    $LBIX & $CLRB drop, $BSPM & $AEGR pop, Money to be made left & right!
                    Reply
                      • timothy russell | Send Message 15 Jun

                        $AEGR nice jump
                        Reply
                          • Jion | Send Message 15 Jun

                            $QLTI $AEGR merger news give both high gains premarket.
                            Reply
                              • Alexander Valtsev | Send Message 17 May

                                Today's Market Insights: LendingClub ($LC), Freeport-McMoRan ($FCX), Aegerion Pharmaceuticals ($AEGR), NQ Mobile $NQ: http://bit.ly/170516LC
                                Reply
                                  • wilkinson99 | Send Message 17 May

                                    $AEGR down 20% on 4.2K volume
                                    Reply
                                      • wilkinson99 | Send Message 17 May

                                        Premarket Top % Losers: $FRAN -20%, $GEN -18%, $LC -10%, $WNRL -8%, $RLYP -7%, $RIC -6%, $CROX -6%, $KTOV -5% $AEGR $PRGN $IL $AMDA $RGLD
                                        Reply
                                          Company Description
                                          Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It is engaged in the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases. The company's lead product, lomitapide, is a small molecule, oral... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States